Exelixis
EXEL
#1726
Rank
โ‚น1.203 T
Marketcap
โ‚น4,787
Share price
-0.34%
Change (1 day)
30.14%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2026 (TTM): โ‚น89.88 Billion

According to Exelixis's latest financial reports the company's current earnings are โ‚น2.37 Billion. In 2025 the company made an earning of โ‚น90.14 Billion, an increase over its 2024 earnings that were of โ‚น65.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น89.88 B-0.29%
2025 โ‚น90.14 B38.08%
2024 โ‚น65.28 B164.69%
2023 โ‚น24.66 B9.89%
2022 โ‚น22.44 B-20.33%
2021 โ‚น28.17 B124.82%
2020 โ‚น12.53 B-67.14%
2019 โ‚น38.12 B-11.94%
2018 โ‚น43.30 B185.09%
2017 โ‚น15.18 B-325.82%
2016 -โ‚น6.73 Billion-58.12%
2015 -โ‚น16.06 Billion-37.61%
2014 -โ‚น25.74 Billion9.75%
2013 -โ‚น23.46 Billion65.96%
2012 -โ‚น14.14 Billion-291.63%
2011 โ‚น7.37 B-195.59%
2010 -โ‚น7.72 Billion-42.17%
2009 -โ‚น13.35 Billion-18.98%
2008 -โ‚น16.47 Billion-6.99%
2007 -โ‚น17.71 Billion46.3%
2006 -โ‚น12.11 Billion33.25%
2005 -โ‚น9.09 Billion-30.92%
2004 -โ‚น13.15 Billion44.29%
2003 -โ‚น9.12 Billion12.86%
2002 -โ‚น8.08 Billion22.79%
2001 -โ‚น6.58 Billion60.14%
2000 -โ‚น4.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.488 T 2,489.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.014 T 955.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น870.33 B 805.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น733.51 B 663.41%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น1.259 T 1,211.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น919.17 B 856.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น958.86 B 897.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-โ‚น3.12 Billion-103.25%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น2.79 Billion-102.89%๐Ÿ‡บ๐Ÿ‡ธ USA